Page 124 - product-manual
P. 124

TM/MC  TM/MC
                                          PHARMACOLOGICAL ACTIVITIES - TOXICOLOGY - DRUG INTERACTIONS






                    Essential Fatty Acids


                    Toxicity  for  essential  fatty  acids  has  not  been  documented  in  dogs  and  cats  when  administered  orally  in
                    therapeutic doses. The LD  values for essential fatty acids have not been determined.
                                          50
                    Some species of fish may contain significant levels of methylmercury, polychlorinated biphenyls (PCBs), or
                    other  environmental  contaminants  (Mozaffarian  &  Rimm,  2006).  In  general,  larger  predatory  fish,  such  as
                TOXICOLOGY  swordfish  (Xiphias gladius),  tend  to  contain  the  highest  levels  of  these  contaminants.  However,  several

                    independent laboratory analyses in the U.S. have found commercially available omega-3 fatty acid supplements
                    to be free of contaminants (ConsumerLab, 2005; Melanson et al., 2005). The absence of methylmercury in
                    omega-3 fatty acid supplements can be explained by the fact that mercury accumulates in the muscle, rather than
                    the fat of fish (Kris et al., 2002). Fish body oils contain lower levels of PCBs and other fat-soluble contaminants
                    than  fish  liver  oils. Additionally,  fish  oils  that  have  been  more  highly  refined  and  deodorized  also  contain
                    lower levels of PCBs (Hilbert et al., 1998). Pyrrolizidine alkaloids, potentially hepatotoxic and carcinogenic
                    compounds,  are  found  in  various  parts  of  the  borage  plant.  Supplements  containing  borage  oil  should  use
                    products that are certified free of pyrrolizidine alkaloids (Hendler & Rorvik, 2001).



                       DRUG    Validated interactions studies do not exist for essential fatty acid preparations.
              INTERACTIONS     A  literature  search  identified  only  three  case  reports  presenting  bleeding  events  or  changes  in
                               laboratory results in human patients taking fish oil and anticoagulant medication (Jalili & Dehpour,
                               2007; McClaskey & Michalets, 2007; Buckley et al., 2004) such as aspirin, clopidogrel, dalteparin,
                               dipyridamole, enoxaparin, heparin, ticlopidine, and warfarin.  However, one small study found that
                               3 g/day or 6 g/day of fish oil did not affect International Normalized Ratio (INR) values in ten
                               patients on warfarin over a 4-week period (Bender et al., 1998). Gamma-linolenic acid supplements,
                               such as evening primrose oil or borage seed oil, may increase the risk of seizures in people on
                               phenothiazines, such as chlorpromazine (Vaddadi, 1981).
                               Studies suggest that the combined use of statins and omega-3 fatty acids improves cardiovascular
                               protection and reduces the cardiovascular disease-related mortality rate (Villalobos et al., 2010).
                               Omega-3 fatty acids do not interfere with the actions of chemotherapy and may potentiate  the
                               effect of some chemotherapeutic agents such as epothilone, 5-fluorouracil and cyclophosphamide
                               (Wynter et al., 2004).





















                                                                                               Omega3/6/9 -VM TM       |  3
   119   120   121   122   123   124   125   126   127   128   129